Literature DB >> 10723677

TNBS-colitis.

M Neurath1, I Fuss, W Strober.   

Abstract

Disease states, such as the occurrence of gastrointestinal inflammation (Crohn's disease and ulcerative colitis), can be secondary to a host of determinants that act in conjunction to bring about pathologic change. The underlying factors that mediate the development of such mucosal inflammation has recently been brought to the forefront with the advent of animal models. The examination of these animal models have given researchers a better understanding of the mechanisms involved in the pathogenesis of inflammatory bowel disease. This review discusses one such model, TNBS-colitis, and the insights that it provides into the occurrence of IBD and its future treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10723677     DOI: 10.3109/08830180009048389

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  76 in total

1.  Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation.

Authors:  Dino J Ravnic; Moritz A Konerding; Akira Tsuda; Harold T Huss; Tanja Wolloscheck; Juan P Pratt; Steven J Mentzer
Journal:  Gut       Date:  2006-11-17       Impact factor: 23.059

2.  Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter.

Authors:  Shehzad Z Sheikh; Taku Kobayashi; Katsuyoshi Matsuoka; Joseph C Onyiah; Scott E Plevy
Journal:  J Biol Chem       Date:  2010-11-21       Impact factor: 5.157

3.  Protective effects of citicoline on TNBS-induced experimental colitis in rats.

Authors:  Rauf Onur Ek; Mukadder Serter; Kemal Ergin; Serpil Cecen; Cengiz Unsal; Yuksel Yildiz; Mehmet D Bilgin
Journal:  Int J Clin Exp Med       Date:  2014-04-15

4.  Induction of murine TNBS colitis is strictly controlled by a modified method using continuous inhalation anesthesia with sevoflurane.

Authors:  Tomohiro Terai; Satoshi Osawa; Shinya Tani; Shinji Oishi; Yoshifumi Arai; Takanori Yamada; Mitsushige Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Hiroaki Miyajima; Ken Sugimoto
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

5.  Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice.

Authors:  In-Ah Lee; Eun-Ah Bae; Yang-Jin Hyun; Dong-Hyun Kim
Journal:  J Inflamm (Lond)       Date:  2010-02-01       Impact factor: 4.981

6.  Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis.

Authors:  Jörn Karhausen; Glenn T Furuta; John E Tomaszewski; Randall S Johnson; Sean P Colgan; Volker H Haase
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation.

Authors:  Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

8.  Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.

Authors:  Lie Di; Shekhar Srivastava; Olga Zhdanova; Yi Ding; Zhai Li; Heike Wulff; Maria Lafaille; Edward Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

9.  Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis.

Authors:  Hon-Wai Koon; You Sun Kim; Hua Xu; Aatish Kumar; Dezheng Zhao; Iordanes Karagiannides; Paul R Dobner; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-14       Impact factor: 11.205

10.  TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis.

Authors:  Mario Noti; Nadia Corazza; Christoph Mueller; Barbara Berger; Thomas Brunner
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.